[Form 4] Fabrinet Insider Trading Activity

Rhea-AI Filing Summary

Fabrinet (FN) Form 4: Harpal Gill, who serves as President & COO and a director, reported a sale of 14,203 ordinary shares on 09/04/2025 at a weighted average price of $355.147 per share (range $355.00 to $355.81). After the transaction Mr. Gill beneficially owned 13,983 shares. The filing was signed by an attorney-in-fact on behalf of Mr. Gill.

The form discloses the exact number of shares sold, the weighted average sale price, and the remaining beneficial ownership. No derivative transactions or amendments are reported.

Positive

• Complete Section 16 disclosure filed showing transaction date, share amounts, and price range
• Clear identification of reporting person and role (President & COO and director)

Negative

• Insider sale of 14,203 shares, which reduces beneficial ownership to 13,983 shares
• No Rule 10b5-1 plan checkbox marked and no explanation of the purpose for the sale beyond price range

Insights

Financial Analyst

TL;DR Insider sale of 14,203 shares at ~$355 per share reduces the President & COO's holdings to 13,983 shares; disclosed per Section 16 rules.

The report documents a single non-derivative sale executed on 09/04/2025, showing precise quantities and a weighted average sale price with a provided price range. For analysts this is a clear, compliant disclosure of insider liquidity activity; it does not include accompanying commentary about purpose, timing plan, or additional transactions. The absence of derivative activity and the single-line reporting simplify interpretation but limit insight into ongoing insider intentions.

Corporate Governance Expert

TL;DR Company officer and director executed a substantial share sale and filed Form 4 as required; disclosure appears complete on face.

The form identifies the reporting person, relationship to the issuer (President & COO and director), transaction date, and exact share counts before/after the sale. The filing includes an explanation that the sale price is a weighted average over a narrow range and states that further breakdown can be provided on request. There is no indication of a Rule 10b5-1 plan checked on the form, and no amendment history is shown. From a governance perspective the document meets the statutory disclosure elements but provides limited context about the rationale or any planned disposition strategy.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gill Harpal

(Last) (First) (Middle)

C/O FABRINET USA, INC.

3736 FALLON ROAD #428

(Street)

DUBLIN CA 94568

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Fabrinet [ FN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT & COO

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	09/04/2025		S		14,203	D	$355.147(1)	13,983	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale price represents the weighted average sale price of the shares sold ranging from $355.00 to $355.81 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	Andrew Chew, Attorney-in-fact for Harpal Gill	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Harpal Gill report on Form 4 for Fabrinet (FN)?

The Form 4 reports a sale of 14,203 ordinary shares on 09/04/2025.

At what price were the Fabrinet shares sold according to the Form 4?

The sale was at a weighted average price of $355.147 per share, with a reported range of $355.00 to $355.81.

How many Fabrinet shares does Harpal Gill beneficially own after the reported sale?

After the transaction Mr. Gill beneficially owned 13,983 shares.

Does the Form 4 show any derivative transactions or amendments?

No. The filing reports only a single non-derivative sale and lists no derivative securities or amendments.

Was the Form 4 signed directly by Harpal Gill?

The signature on the filing is by Andrew Chew, Attorney-in-fact for Harpal Gill, dated 09/04/2025.